These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19682036)

  • 21. Is reduced ornithine-δ-aminotransferase activity the cause of vigabatrin-associated visual field defects?
    Sorri I; Brigell MG; Mályusz M; Mahlamäki E; de Meynard C; Kälviäinen R
    Epilepsy Res; 2010 Nov; 92(1):48-53. PubMed ID: 20850272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steroids or vigabatrin in the treatment of infantile spasms?
    Riikonen RS
    Pediatr Neurol; 2000 Nov; 23(5):403-8. PubMed ID: 11118795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
    Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA
    Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vigabatrin and epilepsy: further lessons in early childhood.
    Parisi P; Bombardieri R; Curatolo P
    Epilepsia; 2008 Jan; 49(1):177-8. PubMed ID: 18184225
    [No Abstract]   [Full Text] [Related]  

  • 25. Revised guideline for prescribing vigabatrin in children. Guideline's claim about infantile spasms is not based on appropriate evidence.
    Lux AL; Edwards SW; Osborne JP; Hancock E; Johnson AL; Kennedy CR; O'Callaghan FJ; Newton RW; Verity CM
    BMJ; 2001 Jan; 322(7280):236-7. PubMed ID: 11159628
    [No Abstract]   [Full Text] [Related]  

  • 26. Balancing clinical benefits of vigabatrin with its associated risk of vision loss.
    Pellock JM
    Acta Neurol Scand Suppl; 2011; (192):83-91. PubMed ID: 22061183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of infantile spasms with sodium valproate followed by benzodiazepines.
    Auvichayapat N; Tassniyom S; Treerotphon S; Auvichayapat P
    J Med Assoc Thai; 2007 Sep; 90(9):1809-14. PubMed ID: 17957923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
    Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
    Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
    Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of infantile spasms in a regional centre before and after the United Kingdom infantile spasms study (UKISS).
    Maheshwari N; Zaiwalla Z; McShane MA
    Arch Dis Child; 2008 May; 93(5):448. PubMed ID: 18426942
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective.
    Ibrahim S; Gulab S; Ishaque S; Saleem T
    BMC Pediatr; 2010 Jan; 10():1. PubMed ID: 20078871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP
    Lancet; 2004 Nov 13-19; 364(9447):1773-8. PubMed ID: 15541450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug approved to treat infantile spasms.
    Thompson CA
    Am J Health Syst Pharm; 2009 Oct; 66(19):1682. PubMed ID: 19767370
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety of vigabatrin in Japanese patients with infantile spasms: Primary short-term study and extension study.
    Ohtsuka Y
    Epilepsy Behav; 2018 Jan; 78():134-141. PubMed ID: 29190579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In utero exposure to vigabatrin: no indication of visual field loss.
    Lawthom C; Smith PE; Wild JM
    Epilepsia; 2009 Feb; 50(2):318-21. PubMed ID: 18616557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of vigabatrin in childhood seizure disorders: results from a clinical audit.
    Prasad AN; Penney S; Buckley DJ
    Epilepsia; 2001 Jan; 42(1):54-61. PubMed ID: 11207785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vigabatrin for the treatment of infantile spasms: final report of a randomized trial.
    Elterman RD; Shields WD; Bittman RM; Torri SA; Sagar SM; Collins SD
    J Child Neurol; 2010 Nov; 25(11):1340-7. PubMed ID: 20404353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of infantile spasms with sodium valproate followed by benzodiazepines.
    Visudhiphan P
    J Med Assoc Thai; 2007 Oct; 90(10):2244. PubMed ID: 18041449
    [No Abstract]   [Full Text] [Related]  

  • 39. [Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms].
    Suzuki-Muromoto, S; Uematsu M; Sato H; Numata-Uematsu Y; Nakayama T; Kiluchi A; Kobayashi T; Hino-Fukuyo N; Kure S
    No To Hattatsu; 2016 Nov; 48(6):413-9. PubMed ID: 30010289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term follow-up of childhood epilepsy treated with vigabatrin outside of clinical trials].
    Garaizar C; Martínez-González MJ; Fernández-Cuesta MA; Prats JM
    Rev Neurol; 1999 Aug 1-15; 29(3):201-7. PubMed ID: 10797902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.